6-[2-[3-(3-Ethyl-5-methyl-1,3-benzoxazol-2-ylidene)prop-1-enyl]-5-methyl-1,3-benzoxazol-3-ium-3-yl]hexanoic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑啉
• 英文名称: 6-[2-[3-(3-Ethyl-5-methyl-1,3-benzoxazol-2-ylidene)prop-1-enyl]-5-methyl-1,3-benzoxazol-3-ium-3-yl]hexanoic acid
• 化学式: C27H31N2O4+
• 分子量: 447.5
• InChiKey: YOERGOPYLAMOEB-UHFFFAOYSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• [EN] TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS<br/>[FR] ADMINISTRATION CIBLÉE D'UN MÉDICAMENT FAISANT APPEL À DES COUPLEURS FONDÉS SUR L'AFFINITÉ
  申请人：INVICTUS ONCOLOGY PVT LTD

  公开号：WO2015148126A1

  公开（公告）日：2015-10-01

  The current invention discloses targeted drug delivery conjugates comprising a targeting moiety linked to a drug via a molecule having an affinity for the targeting moiety. Typically, the conjugate comprises a targeting ligand and a molecule of interest, e.g., a therapeutic agent. The targeting ligand and the molecule of interest are linked to each other via an affinity ligand. The affinity ligand is further covalently or non-covalently linked to a drug or therapeutic agent. The drug can be modified to make it more soluble and so that it cleaves from the linking molecule at the target site.

  当前的发明揭示了包括通过具有与靶向基团亲和力的分子连接到药物的靶向药物传递共轭物。通常，该共轭物包括一个靶向配体和一个感兴趣的分子，例如，一个治疗剂。靶向配体和感兴趣的分子通过一个亲和配体相互连接。该亲和配体进一步以共价或非共价方式连接到药物或治疗剂。药物可以被修改以使其更溶解，并使其在靶点处从连接分子中解离。
• COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES
  申请人：Aquinnah Pharmaceuticals, Inc.

  公开号：US20180305334A1

  公开（公告）日：2018-10-25

  Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

  本文描述了与神经退行性疾病、肌肉骨骼疾病、癌症、眼科疾病和病毒感染相关的细胞内包涵体形成和应激颗粒的调节化合物、组合物和方法。
• [EN] SULFONAMIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] DÉRIVÉS DE SULFONAMIDE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION DANS LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
  申请人：AQUINNAH PHARMACEUTICALS INC

  公开号：WO2016090317A1

  公开（公告）日：2016-06-09

  Herein, compounds of formula (I), compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

  本文描述了公式（I）化合物、组合物和调节与神经退行性疾病、肌肉骨骼疾病、癌症、眼科疾病和病毒感染相关的细胞内包涵体形成和应激颗粒的方法。
• [EN] ANTHRAQUINONE QUENCHER DYES, THEIR METHODS OF PREPARATION AND USE<br/>[FR] COLORANTS EXTINCTEURS DE FLUORESCENCE A BASE D'ANTHRAQUINONE ET PROCEDES DE FABRICATION ET D'UTILISATION
  申请人：INTEGRATED DNA TECH INC

  公开号：WO2004026804A1

  公开（公告）日：2004-04-01

  The invention provides novel anthraquinone compositions that are useful as broad-spectrum quenchers of fluorescence and provides methods for making and using them. The anthraquinone quenchers can be conjugated to a variety of biologically relevant compounds, including lipids, nucleic acids, polypeptides, and more specifically antigens, steroids, vitamins, drugs, haptens, metabolites, toxins, environmental pollutants, amino acids, peptides, proteins, nucleotides, oligonucleotides, polynucleotides, carbohydrates, and their analogs. The invention also provides kits comprising, in one or more containers, at least one anthraquinone quencher dye composition of the present invention, and instructions for using that composition.

  该发明提供了一种新型蒽醌组合物，可作为广谱荧光猝灭剂，并提供了制备和使用它们的方法。蒽醌猝灭剂可以与各种生物相关化合物结合，包括脂质、核酸、多肽等特异抗原、类固醇、维生素、药物、半抗原、代谢产物、毒素、环境污染物、氨基酸、肽、蛋白质、核苷酸、寡核苷酸、多核苷酸、碳水化合物及其类似物。该发明还提供了包括至少一个本发明的蒽醌猝灭剂染料组合物的工具箱，其中工具箱中包含一个或多个容器，并包含使用该组合物的说明书。
• [EN] COMPOUNDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS D'UTILISATION ASSOCIÉS
  申请人：AQUINNAH PHARMACEUTICALS INC

  公开号：WO2016090313A1

  公开（公告）日：2016-06-09

  Herein, compounds of Formula (I) or (II), compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

  本文描述了公式（I）或（II）的化合物、组合物和方法，用于调节与神经退行性疾病、肌肉骨骼疾病、癌症、眼科疾病和病毒感染相关的细胞内包涵体形成和应激颗粒。